❮ Back to Researchers

Bobby Yanagawa

MD, FRCSC, PhD

Investigator

Email: Bobby.Yanagawa@unityhealth.to
Tel: 416-864-6060 Ext 5465

Research Programs

Biography

Please note: Dr. Yanagawa is not taking any students in.

Dr. Yanagawa is a Surgeon and the Program Director in the Division of Cardiovascular Surgery at St. Michael’s Hospital and Associate Professor in the Department of Medicine at the University of Toronto. He completed residency training at the University of Toronto and INOVA Fairfax Hospital (Fairfax , VA) and an advanced valvular fellowship at Mount Sinai Hospital (New York, NY). His research training includes a PhD at the University of British Columbia and post-doctoral fellowships at the University of Wales College of Medicine (Cardiff, UK) and National Cardiovascular Center (Osaka, Japan). His clinical focus is surgical revascularization and surgery for infective endocarditis. He is the Director of the Canadian Society of Cardiac Surgeons National Training Bootcamp. His research interests include clinical outcome studies of ischemic and valvular heart disease. He has published over 80 peer-reviewed articles, 30 reviews and 15 book chapters.

Recent Publications

  1. Hibino, M, Pandey, AK, Hibino, H, Verma, R, Aune, D, Yanagawa, B et al.. Mortality trends of aortic stenosis in high-income countries from 2000 to 2020. Heart. 2023; :. doi: 10.1136/heartjnl-2023-322397. PubMed PMID:37208159 .
  2. Hibino, M, Verma, S, Pandey, AK, Bisleri, G, Yanagawa, B, Verma, R et al.. The Impact of Statins on Postdischarge Atrial Fibrillation After Cardiac Surgery: Secondary Analysis from a Randomized Trial. CJC Open. 2023;5 (4):285-291. doi: 10.1016/j.cjco.2022.12.012. PubMed PMID:37124963 PubMed Central PMC10140742.
  3. Pandey, AK, Dhingra, NK, Pandey, A, Puar, P, Ahmed, S, Verma, R et al.. Efficacy of sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors for heart failure in black patients: a systematic review and meta-analysis of randomized controlled trials. Eur J Heart Fail. 2023;25 (4):591-593. doi: 10.1002/ejhf.2825. PubMed PMID:36919580 .
  4. Hibino, M, Halkos, ME, Murphy, DA, Dhingra, NK, Verma, R, Hibino, H et al.. Age period cohort analysis of rheumatic heart disease in high-income countries. Clin Res Cardiol. 2023; :. doi: 10.1007/s00392-023-02168-6. PubMed PMID:36820872 .
  5. Bisleri, G, Pandey, AK, Verma, S, Ali Hassan, SM, Yanagawa, B, Khandaker, M et al.. Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;81 (6):606-619. doi: 10.1016/j.jacc.2022.11.039. PubMed PMID:36754519 .
  6. Rumman, RK, Verma, S, Chan, V, Mazer, D, Quan, A, Hibino, M et al.. Predictors of mitral valve haemodynamics after mitral valve repair for degenerative mitral regurgitation. Heart. 2023;109 (11):866-873. doi: 10.1136/heartjnl-2022-321753. PubMed PMID:36750353 .
  7. Hassan, SMA, Ghunaim, A, Verma, R, Sicilia, A, Yanagawa, B. Racial and ethnic differences in aortic stenosis: the tip of the iceberg. Curr Opin Cardiol. 2023;38 (2):103-107. doi: 10.1097/HCO.0000000000001019. PubMed PMID:36718619 .
  8. Elfaki, L, Nwakoby, A, Lia, H, Zhao, G, Sicila, A, Yoshida, N et al.. Engaging medical students in cardiac surgery: a focus on equity, diversity, and inclusion. Curr Opin Cardiol. 2023;38 (2):94-102. doi: 10.1097/HCO.0000000000001010. PubMed PMID:36656289 .
  9. Krishnaraj, A, Bakbak, E, Teoh, H, Bhatt, DL, Quan, A, Puar, P et al.. Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease. Med. 2023;4 (2):130-138.e1. doi: 10.1016/j.medj.2022.12.008. PubMed PMID:36630964 .
  10. Stoklosa, K, Mazine, A, Forgie, KA, Brown, A, Hage, A, Ridwan, K et al.. Opening the "Black Box" for Canadian Cardiac Surgery Residency Applicants∗. CJC Open. 2022;4 (11):979-988. doi: 10.1016/j.cjco.2022.07.017. PubMed PMID:36444372 PubMed Central PMC9700213.
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Department of Surgery, University of Toronto